2Stamberj. Vaccaro Oneaton. JD et al. Diabetes. Other nisk-factor and 12 - yr cardiovas culor mortality for men scnened with Multiple Risk Factor Intervertion Trid Diabetes Care 1993 ;16:434.
3Domingo TL. Gomei M. Liobet J M. et al, Oral vanadion adminis- tration to strertozotocin diabetic rats has marked regative sideeffects whiehare independent of the form of vandium used Toxicogu 1991;66:279.
4Vankatesan N. AvidineA and Davidson MB. Autidiabetic ation of Vanadyl in rats independent of in vivo insulinreceptor kinase activity Diabetes 1991;40:492.
4Tasaka y,Yanagisawa k,Iwamoto Y,et al.Human plasma leptin in obese subjects and diabetes〔J〕[].The Journal of Endocrinology.1997
5Mark AL,Shaffer RA,Correia MLG,et al.Contrasting blood pressure effects of obesity in leptin deficient ob/ob mice and agouti yellow obese mice[].Journal of Hypertension.1999
6Heymsfield IS.Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial[].The Journal of The American Medical Association.1999
7Ogawa Y,Masuzaki H,Hosoda K,et al.Increased glucose metabolism and insulin sensitivity in Transgenic Skinny Mice overexpressing leptin[].Diabetes.1999
8Passaro A,Calzoni F,Zamboni PF,et al.Role of diabetes in influencing leptin concrenatration in elderly overweight patients[].European Journal of Endocrinology.2001
9Assali AR,Ganor A,Beigel Y,et al.Insulin resistance inobesity: body-weight or energy balance? 〔J〕[].The Journal of Endocrinology.2001
10Bastard JP,Jardel C,Bruckert E,et al.Elevated levels of interleukin 6 reduced in serum and subcutaneous adipose tissue of obese women after weight loss〔J〕[].The Journal of Clinical Endocrinology.2000
